Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BICALUTAMIDE for Neoplasm prostate: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where BICALUTAMIDE was used for Neoplasm prostate.

Most Reported Side Effects for BICALUTAMIDE

Side Effect Reports % Deaths Hosp.
Malignant neoplasm progression 352 8.7% 52 43
Prostatic specific antigen increased 322 7.9% 18 41
Drug ineffective 268 6.6% 46 38
Fatigue 258 6.4% 22 79
Prostate cancer 258 6.4% 35 74
Asthenia 223 5.5% 6 57
Hot flush 219 5.4% 10 21
Off label use 171 4.2% 21 51
Disease progression 169 4.2% 26 28
Anaemia 164 4.0% 35 86
Death 164 4.0% 164 24
Metastases to bone 164 4.0% 26 23
Dyspnoea 128 3.2% 15 61
Nausea 127 3.1% 5 45
Interstitial lung disease 118 2.9% 41 65

Other Indications for BICALUTAMIDE

Prostate cancer (1,832) Product used for unknown indication (732) Prostate cancer metastatic (338) Hormone-refractory prostate cancer (87) Antiandrogen therapy (45) Metastases to bone (38) Hormone-dependent prostate cancer (32) Salivary gland cancer (31) Prostatic specific antigen increased (25) Hormone therapy (21)

Other Drugs Used for Neoplasm prostate

ENZALUTAMIDE (401) LEUPROLIDE (73) ABIRATERONE (50) DOCETAXEL (48) ZOLEDRONIC ACID (22) APALUTAMIDE (17) DENOSUMAB (16) OLAPARIB (9) DEVICE (8) TRIPTORELIN (8)

Related Pages

BICALUTAMIDE Full Profile All Neoplasm prostate Drugs BICALUTAMIDE Demographics BICALUTAMIDE Timeline